117360-45-9

Basic information

• Product Name: 1-Cyclohexene-1-methanol, 2-bromo-
• CAS NO: 117360-45-9
• Molecular Formula: C7H11BrO
• Molecular Weight: 191.068
• Mol File: 117360-45-9.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: 1-Cyclohexene-1-methanol, 2-bromo-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Cyclohexene-1-methanol, 2-bromo-(117360-45-9)
• EPA Substance Registry System: 1-Cyclohexene-1-methanol, 2-bromo-(117360-45-9)

Safety Data

• Hazardous Substances Data: 117360-45-9(Hazardous Substances Data)

Usage

Chemical class

Cyclohexene derivatives

Physical state

Colorless liquid

Molecular weight

195.07 g/mol

Uses

a. Organic synthesis
b. Intermediate in pharmaceuticals and agrochemicals production

Reactivity

Nucleophilic agent in various chemical reactions

Toxicity

Moderate toxicity

Safety precautions

Handle with care and follow proper safety guidelines

Upstream product

• 108-94-1 cyclohexanone 
• 68-12-2 N,N-dimethyl-formamide 
• 38127-47-8 2-bromocyclohex-1-ene-1-carbaldehyde 

Downstream Products

• 1007834-63-0 N-(cyclohex-1-enylmethyl)benzenamine 
• 1027499-29-1 3-[2-hydroxy-2-(2-hydroxymethyl-cyclohex-1-enyl)-ethyl]-1,5-dioxa-spiro[5.5]undec-3-en-2-one 
• 1192-88-7 1-cyclohexene-1-carboxaldehyde 
• 121898-42-8 (2-Bromocyclohex-1-enyl)methyl bromide 
• 117361-06-5 1-(benzyloxymethyl)-2-bromo-1-cyclohexene 
• 100869-87-2 2-phenyl-5,6,7,8-tetrahydroquinazoline 

Relevant articles and documents

Enantioselective fluoroamination: 1,4-addition to conjugated dienes using anionic phase-transfer catalysis

Chiral-anion phase-transfer catalysis (PTC) has been applied towards the enantioselective fluorocyclization reactions of 1,3-dienes. The method affords unprecedented fluorinated benz[f]isoquinoline and octahydroisoquinoline products in high yields and up

CYCLOHEXEN-1-YL-PYRIDIN-2-YL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacolo

Palladium-catalyzed carbonylative cyclization of 1-bromoallyl bromides with anilines leading to 1-aryl-1H-pyrrol-2(5H)-ones

1-Bromoallyl bromides are carbonylatively cyclized with anilines under carbon monoxide pressure in DMF in the presence of a catalytic amount of a palladium catalyst along with a base to give the corresponding 1-aryl-1H-pyrrol-2(5H)-ones in moderate to goo